A randomized, double-blind study to evaluate the acid-inhibitory effect of vonoprazan (20 mg and 40 mg) in patients with proton-pump inhibitor-resistant erosive esophagitis. [electronic resource]
- Therapeutic advances in gastroenterology Jun 2017
- 439-451 p. digital